Recognizable vascular skin manifestations of SARS‐CoV‐2 (COVID‐19) infection are uncommon in patients with darker skin phototypes.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): Pangti, R. (AUTHOR); Gupta, S. (AUTHOR); Nischal, N. (AUTHOR); Trikha, A. (AUTHOR)
  • Source:
    Clinical & Experimental Dermatology. Jan2021, Vol. 46 Issue 1, p180-182. 3p. 1 Color Photograph, 1 Chart.
  • Additional Information
    • Subject Terms:
      COVID-19; SARS-CoV-2; ACUTE myeloid leukemia; CUTANEOUS manifestations of general diseases; SOUTH Asians; CHRONIC myeloid leukemia
    • Abstract:
      Recognizable vascular skin manifestations of SARS-CoV-2 (COVID-19) infection are uncommon in patients with darker skin phototypes Reported cutaneous manifestations of SARS-Cov-2 infection include maculopapular rash, urticarial rash, varicelliform or vesicular lesions, petechiae/purpura, livedoid/necrotic lesions, chilblain-like lesions ("COVID toes"), erythema multiforme-like lesions1 and aphthous ulcers.2 These cutaneous manifestations have been mostly reported from countries with populations of lighter skin phototypes, with a paucity of data from the populations with darker skin phototypes.3 We conducted a prospective study to report the prevalence and patterns of cutaneous manifestations in patients with COVID-19 from India. All 10 patients had Fitzpatrick skin types IV or V. In all our patients, the cutaneous features followed the symptoms of COVID-19. 1 TableDetails of the patients possible COVID-19-related cutaneous features included in the study. [Extracted from the article]
    • Abstract:
      Copyright of Clinical & Experimental Dermatology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)